Home / Market News / $ANIK

$ANIK news and market catalysts

The 5 most recent market catalysts affecting $ANIK, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

5 catalysts 2 high impact 4 bullish 0 bearish Healthcare
Nov 7, 2026 Corporate Catalyst Bullish Impact 85
Anika Therapeutics Reports Third Quarter 2026 Financial Results and Raises 2026 Guidance
Anika Therapeutics reported a 10% increase in Q3 2026 revenue to $30.6 million, leading them to raise the lower end of their full-year revenue guidance and increase adjusted EBITDA…
Nov 6, 2026 Corporate Catalyst Neutral Impact 75
Anika Therapeutics Reports Third Quarter 2026 Financial Results
Anika Therapeutics announced its third-quarter 2026 financial results, revealing a 10% increase in total revenue to $30.6 million compared to the prior year. This growth was attrib…
Jul 30, 2026 Corporate Catalyst Bullish Impact 60
B. Riley Securities Maintains Buy on Anika Therapeutics, Raises Price Target to $21
B. Riley Securities analyst Anderson Schock has maintained a 'Buy' rating on Anika Therapeutics (ANIK) and raised the price target from $18 to $21. This action signals increased co…
Jul 29, 2026 Corporate Catalyst Bullish Impact 85
Anika Therapeutics shares are trading higher after the company reported better-than-expected Q2 sales results and raised its FY26 sales guidance with its midpoint above estimates.
This headline represents a strong positive corporate catalyst for Anika Therapeutics. Better-than-expected sales demonstrate current operational strength, while raising future guid…
Jul 29, 2026 Corporate Catalyst Bullish Impact 75
Anika Therapeutics Raises FY2026 Sales Guidance from $114.000M-$122.500M to $118.460M-$124.101M vs $118.612M Est
Anika Therapeutics (ANIK) has revised its FY2026 sales outlook upwards, moving from a range of $114.000M-$122.500M to $118.460M-$124.101M. This is significant because the new guida…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.